BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32356447)

  • 1. miR-485-3p suppresses colorectal cancer via targeting TPX2.
    Taherdangkoo K; Kazemi Nezhad SR; Hajjari MR; Tahmasebi Birgani M
    Bratisl Lek Listy; 2020; 121(4):302-307. PubMed ID: 32356447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of TRX2 by miR-330-3p in melanoma inhibits proliferation.
    Yao Y; Zuo J; Wei Y
    Biomed Pharmacother; 2018 Nov; 107():1020-1029. PubMed ID: 30257313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-29c Suppresses the Malignant Phenotype of Hepatocellular Carcinoma Cells In Vitro by Mediating TPX2 Associated with Immune Infiltration.
    Wang H; Chen W; Qi Y; Liu D; Liu Z; Zhang Q; Yi Y; Wang J; Wu W
    Dig Dis Sci; 2023 May; 68(5):1923-1935. PubMed ID: 36583803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1.
    Xu X; Chen R; Li Z; Huang N; Wu X; Li S; Li Y; Wu S
    BMC Cancer; 2015 Dec; 15():1023. PubMed ID: 26714817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-548a-3p Weakens the Tumorigenesis of Colon Cancer Through Targeting TPX2.
    Wang M; Yang M; Deng B
    Cancer Biother Radiopharm; 2022 Dec; 37(10):917-926. PubMed ID: 32857606
    [No Abstract]   [Full Text] [Related]  

  • 6. MiR-491 suppresses migration and invasion via directly targeting TPX2 in breast cancer.
    Tan GZ; Li M; Tan X; Shi ML; Mou K
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9996-10004. PubMed ID: 31799669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-142-3p Suppresses Cell Growth by Targeting CDK4 in Colorectal Cancer.
    Zhu X; Ma SP; Yang D; Liu Y; Wang YP; Lin T; Li YX; Yang SH; Zhang WC; Wang XL
    Cell Physiol Biochem; 2018; 51(4):1969-1981. PubMed ID: 30513513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of long noncoding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p.
    Shang AQ; Wang WW; Yang YB; Gu CZ; Ji P; Chen C; Zeng BJ; Wu JL; Lu WY; Sun ZJ; Li D
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G222-G232. PubMed ID: 31125260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D.
    Yan L; Yao J; Qiu J
    Biomed Pharmacother; 2017 Dec; 96():974-981. PubMed ID: 29221726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
    Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer.
    Zhao D; Sui Y; Zheng X
    Oncol Rep; 2016 Feb; 35(2):1075-82. PubMed ID: 26718987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-202-3p inhibits cell proliferation by targeting ADP-ribosylation factor-like 5A in human colorectal carcinoma.
    Wang Q; Huang Z; Guo W; Ni S; Xiao X; Wang L; Huang D; Tan C; Xu Q; Zha R; Zhang J; Sheng W; He X; Du X
    Clin Cancer Res; 2014 Mar; 20(5):1146-57. PubMed ID: 24327274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biological significance of miR-193a-3p targeted KRAS in colorectal cancer pathogenesis.
    Mamoori A; Wahab R; Islam F; Lee K; Vider J; Lu CT; Gopalan V; Lam AK
    Hum Pathol; 2018 Jan; 71():145-156. PubMed ID: 29104111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA HOTAIR is a Prognostic Biomarker for the Proliferation and Chemoresistance of Colorectal Cancer via MiR-203a-3p-Mediated Wnt/ß-Catenin Signaling Pathway.
    Xiao Z; Qu Z; Chen Z; Fang Z; Zhou K; Huang Z; Guo X; Zhang Y
    Cell Physiol Biochem; 2018; 46(3):1275-1285. PubMed ID: 29680837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of miR-301a-3p promotes colorectal cancer cell proliferation and metastasis by targeting deleted in liver cancer-1 and runt-related transcription factor 3.
    Zhang L; Zhang Y; Zhu H; Sun X; Wang X; Wu P; Xu X
    J Cell Biochem; 2019 Apr; 120(4):6078-6089. PubMed ID: 30362160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression.
    Bai R; Weng C; Dong H; Li S; Chen G; Xu Z
    Int J Cancer; 2015 Nov; 137(10):2310-22. PubMed ID: 25991585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-216a-3p inhibits colorectal cancer cell proliferation through direct targeting COX-2 and ALOX5.
    Wang D; Li Y; Zhang C; Li X; Yu J
    J Cell Biochem; 2018 Feb; 119(2):1755-1766. PubMed ID: 28786533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [miR-491 inhibits the proliferation, invasion and migration of hepatocellular carcinoma cell via down-regulating TPX2 expression].
    Wang J; Liu Z; Dou C; Han S; Li C; Tu K; Yang W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Apr; 32(4):512-7. PubMed ID: 27053618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expression.
    Liu H; Liu Y; Sun P; Leng K; Xu Y; Mei L; Han P; Zhang B; Yao K; Li C; Bai J; Cui B
    Clin Sci (Lond); 2020 Feb; 134(4):419-434. PubMed ID: 32065214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.